﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/operations-disrupted-at-natco-pharmas-manali-chennai-factory-14983</loc><lastmod>2023-12-08T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/ttk-healthcare-halts-operation-at-ortho-implants-plant-at-ambattur-14984</loc><lastmod>2023-12-08T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/sarclisa-phase-3-trial-met-primary-endpoint-of-progression-free-survival-with-newly-diagnosed-multiple-myeloma-not-eligible-for-transplant-14985</loc><lastmod>2023-12-08T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/novartis-receives-fda-approval-for-fabhalta-as-the-first-oral-monotherapy-for-adults-with-pnh-14986</loc><lastmod>2023-12-08T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/abelzeta-pharma-astrazeneca-to-co-develop-a-novel-gpc3-armored-car-t-therapy-in-china-14987</loc><lastmod>2023-12-08T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>